Osaka International Cancer Institute(OICI)

Osaka 541-8567

1 studies enrolling now · 2 studies all time

What they study most

Carcinoma, Small Cell Lung, HER2-Positive Primary Breast Cancer, Lung Neoplasms, Residual Invasive Breast Cancer, Small Cell Cancer Of The Lung, Small Cell Lung Cancer, Small Cell Lung Cancer ( SCLC ), Transformed Small Cell Lung Cancer

Studies at this site

• Symbiotic-Lung-14: A Study to Learn About the Study Medicine Called PF08634404 in Combination With Chemotherapy in Adult Participants With Transformed Small Cell Lung Cancer — Recruiting now
• A Study of Trastuzumab Deruxtecan (T-DXd) Versus Trastuzumab Emtansine (T-DM1) in High-risk HER2-positive Participants With Residual Invasive Breast Cancer Following Neoadjuvant Therapy (DESTINY-Breast05) — Running, not enrolling